In partnership with
When Silence Screams
Most people can manage their tinnitus during the day. Background noise helps. Work helps. Even conversation may help. Our busy world gives our brain many things to track - for some sufferers, that can move tinnitus to the background.
Then you lay your head down on the pillow.
The TV is off. Your partner is asleep. The room is dark. And the sound that was manageable earlier in the day, becomes the only thing left in the room. For a lot of people with tinnitus, night is when it becomes impossible to ignore.
This is our second deep dive on Tinnitus. We learned three things that have shifted since:
The sleep problem may be the real crisis point for many.
A UK company is building bone-conduction wearables specifically for tinnitus relief.
Regulatory changes that could make clinical-grade devices easier to bring to market and more accessible.
Let’s dive in….
🌙 Tinnitus vs. Sleep
Up to 70% of people with tinnitus report insomnia or poor sleep. That is not a side effect. For many people, it is the main symptom.
Silence increases contrast. When external sound drops away, the internal sound has nothing to compete with. The brain locks onto it. Heart rate goes up. Sleep gets delayed. The next day is harder. Stress rises. The tinnitus feels worse. The cycle feeds itself.
That is why so many tinnitus strategies eventually land on the same practical question: How do I negotiate sleep?
Sound enrichment is the classic answer — white noise machines, fans, apps, pillow speakers, hearing aids with tinnitus programs. The goal is not to drown the tinnitus out completely. The goal is to reduce the contrast enough that the nervous system stops treating the sound like an emergency.
The problem has always been the delivery system. Hearing aids hurt when you sleep on your side. Headphones are hot if not impossible. A bedside speaker can bother a partner. And many of the better clinical tools still require appointments, fittings, and four-figure price tags.
Which is why the next wave of tinnitus products is starting to look less like clinic equipment and more like sleep tech and wearables.
Three things:
Nighttime is often when tinnitus becomes most distressing — not because the sound changes, but because everything else goes quiet.
Sound enrichment works by reducing contrast, not by “curing” the sound.
The product gap has been practical: people need relief that works in bed, does not require a clinic visit, and does not wake anyone else up.
Our take: If you only measure tinnitus by daytime functioning, you miss half the condition. For a huge number of people, the real test is whether they can fall asleep with a sound only they can hear.
👓 Bone Conduction Delivers For Some
Sonovo is a UK company building non-medical tinnitus relief devices around one idea: deliver useful sound through bone conduction so the ears stay open, the experience stays discreet, and the product fits real life.
Founder Jack Bridge developed tinnitus during COVID in 2021. He describes the early period the way a lot of people do — inconsistent sounds, sleep disruption, limited support, and a market full of options that felt uncomfortable, overpriced, or impractical. Sonovo came out of that frustration.
The company is a Tinnitus UK corporate partner and donates 5% of every purchase to the charity. Tinnitus UK is careful to note that partnership is not product endorsement.
What makes Sonovo interesting is not a claim of cure. They do not make one. The pitch is sound enrichment and habituation support in form factors people might actually use.
Sonata 2.0 is the sleep product. It is an under-pillow bone-conduction speaker, currently listed around £59.99. You place it under the pillow, play built-in white noise or Bluetooth audio, and the sound travels through vibration rather than through open-air speakers or in-ear buds. The appeal is obvious: no earbuds, partner-friendly localization, sleep in any position, open ears.
Sonovo Sonata 2.0
Sonovo Unison is the daytime product. These are prescription-ready bone-conduction glasses that amplify ambient sound and support open-ear listening. Retail price is around US$540. Nothing goes in or over the ear. The idea is to keep external sound available throughout the day so tinnitus has less empty space to fill — a wearable version of the same contrast-reduction principle.
Sonovo Unison
Three things:
Sonovo is non-medical sound enrichment, not a regulated tinnitus treatment device. That keeps access simple — and means expectations should stay practical, not clinical.
The product design is the story: under-pillow sleep support and glasses-based daytime enrichment, not another pair of earbuds you will hate by midnight.
The Tinnitus UK partnership and 5% donation model matters. This is a company explicitly building inside the tinnitus community.
Our take: Sonovo sits at the intersection of two things we care about at hearUcan: tinnitus relief, and the shift from medical-looking gear to wearable, livable design. It will not replace evidence-backed clinical options for severe tinnitus. But for the huge middle of people who need something tonight, not after a six-week wait for a specialist, bone-conduction sleep and smart glasses products are a smart category to watch.So
📋 The FDA is Paying Attention
In June 2026, the FDA issued a final order classifying combined acoustic and electrical external stimulation devices for the relief of tinnitus as Class II medical devices with special controls.
In plain English: the category of devices that combine sound with external electrical nerve stimulation — the class Lenire belongs to — now has a clearer regulatory home.
Instead of every new entrant fighting through the heaviest pathway by default, the FDA has defined what “this kind of device” is, what evidence it needs, and how it should be controlled.
Lenire has shown that bimodal neuromodulation can produce meaningful real-world results. We covered that evidence in our earlier tinnitus issue. What has been slower is the broader market response — more devices, more clinics, more insurance pathways, more price competition.
A formal Class II classification does not magically make tinnitus care affordable. It is an unglamorous step that usually comes before a category expands. Clearer rules lower uncertainty for manufacturers, clinicians, and eventually payers/users.
Three things:
This is not a new consumer product launch. It is infrastructure — the FDA defining the lane for a device type.
Class II with special controls still requires real performance evidence. This is not deregulation; it is categorization.
If more companies can enter a defined pathway, patients eventually benefit through access, iteration, and competition.
Our take: The tinnitus field has had a long stretch where the options felt far apart: free apps and white noise on one end, expensive clinic-only systems on the other. Wearables like Sonovo are filling the practical middle. Regulatory clarity around these devices may eventually strengthen the clinical environment as well.
The people living with tinnitus need both.
One Death, Higher Taxes
Here's the math most couples never see coming.
When one spouse passes, the survivor usually keeps most of the household income — but starts filing as a single taxpayer. Same IRA. Same required distributions. Roughly half the standard deduction, and tax brackets that compress to nearly twice the rate at the same income.
It's called the survivor's tax trap, and it's one of the most preventable problems in retirement — if you act while both spouses are alive and rates are still low.
Craig Wear, CFP®, has walked 3,000+ families with $1M+ in IRAs through exactly this planning. His new book, Roth Conversion Reset, lays out the year-by-year framework for converting at today's rates so the tax problem never lands on the person you love most.
The book is free. Full PDF, in your inbox in minutes.